Crossmark

Clinical Challenge: Proactive Precise Management of Active Ulcerative Colitis During Pregnancy—Advantages of Point-of-Care Intestinal Ultrasound and Therapeutic Drug Monitoring

Crossref DOI link: https://doi.org/10.1007/s10620-022-07532-6

Published Online: 2022-05-17

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gottlieb, Zoë S.

Dolinger, Michael

Kayal, Maia

Rao, Bhavana Bhagya

Bhattacharya, Abhik

Dubinsky, Marla C.

Ungaro, Ryan C.
License Information

Text and Data Mining valid from 2022-05-17

Version of Record valid from 2022-05-17
More Information

Article History

Accepted: 19 April 2022

First Online: 17 May 2022

Declarations

:

: ZSG, MK, BBR, and AB have nothing to disclose. MCD is a consultant for Neurologica Corp., a subsidiary of Samsung Electronics Co., Ltd. MCD is a consultant and advisory board member for Abbvie, Arena, Calgene, Eli Lilly, Gilead, Janssen, Pfizer, Prometheus Labs, Takeda, and UCB, and co-Founder and shareholder of Trellus Health. RCU has served as an advisory board member or consultant for AbbVie, Eli Lilly, Janssen, Pfizer, and Takeda; and research support from AbbVie, Boehringer Ingelheim, and Pfizer.

Document is current

Any future updates will be listed below